Home \ Expert Opinion \ Features of the conduct of elderly patients in clinical practice

Features of conducting elderly patients in clinical practice

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

03:14
The structure of medical care for elderly and senile patients. The role of the geriatricra.
05:22
The problem of conducting elderly patients
08:33
Features of pharmacotherapy of elderly and senile patients
10:50
Cognitive disorders and their relationship with age
15:00
The choice of neurocytoprotective therapy
18:10
Mexidol®: Properties and clinical research
20:50
The role of Mexidol® in eliminating mitochondrial dysfunction.
22:00
Subanaliz of the drug Mexidol® in different age groups.

Ostroumova Olga Dmitrievna - MD, professor, head. Department of Therapy and Polymorbid Pathology. Academician M.S. VLUSSi FSBEI DPO RMANPO of the Ministry of Health of Russia

Bogolepova Anna Nikolaevna - MD, professor of the Department of Neurology, Neurosurgery and Medical Genetics of Faculty of Faculty of FGAOU in RNIMU named after N.I. Pirogov of the Ministry of Health of Russia

Announcement:

The free-radical theory of aging explains the violation of the balance in pro- and antioxidant systems, which leads to mitochondrial dysfunction and early aging. Experimental studies with animals have shown that Mexidol ® activates mitochondrial functioning processes and eliminates mitochondrial dysfunction. This leads to results such as an increase in the life expectancy of animals and normalizing their behavioral reactions. Accordingly, taking Mexidol® in old age is able to improve the quality and lifespan.

All video next video

Syndrome of attention deficit with hyperactivity as an interdisciplinary problem. Mexidol® children with ADHD

Age continuum of ischemic-hypoxic lesions of the brain. The use of Mexidol for ADHD in children and adults

Rehabilitation after Covid-19

Mexidol®. Rehabilitation after coronavirus

The effectiveness of Mexidol in a comorbid patient: with arterial hypertension, coronary heart disease, brain ischemia

Mexidol's effectiveness in a polymorbid patient

Features of conducting elderly patients in clinical practice

Mexidol®-Anti-Age (anti-aging) drug

Dorsopathy in general clinical practice

Mexidol® with degenerative diseases in the spine, neck pain, dizziness, brain ischemia

Time codes:

03:14
The structure of medical care for elderly and senile patients. The role of the geriatricra.
05:22
The problem of conducting elderly patients
08:33
Features of pharmacotherapy of elderly and senile patients
10:50
Cognitive disorders and their relationship with age
15:00
The choice of neurocytoprotective therapy
18:10
Mexidol®: Properties and clinical research
20:50
The role of Mexidol® in eliminating mitochondrial dysfunction.
22:00
Subanaliz of the drug Mexidol® in different age groups.

Block of articles on this topic

Features of pharmacotherapy of vascular cognitive impairment in elderly people

Author:
A.N. Bogolepova ^1, ²

¹ FGAOU in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
² FSBI "Federal Center for Brain and Neurotechnology" of the Federal Medical and Biological Agency of Russia, Moscow, Russia

Approaches to pharmacotherapy of vascular moderate cognitive disorders in patients of various age groups

Authors:
V.V. Zakharov ¹ , A.I. Fedin ² , E.A. Mkhitaryan ^2, ³

The effectiveness of Mexidol in patients of different age groups with chronic brain ischemia with cognitive disorders (the results of subanalysis of the international multicenter randomized double blind placebo-controlled study of memes)

Authors:
V.V. Zakharov ¹ , O.N. Tkacheva ^2, ³ , E.A. Mkhitaryan ^2, ³ , A.I. Fedin ²

Cognitive disorders in the practice of a primary link: Focus for patients with arterial hypertension

Authors:
O.D. Ostroumova, A.I. Kochetkov, N.A. Shatalova

Cognitive disorders of vascular genesis in the practice of the therapist

Author:
P.R. Kamchatnov ¹ , R.A. Cheremin ² , L.A. Scepterova ² , A.V. Chugunov ¹

¹ FGAOU in Russian National Medical University named after N.I. Pirogova ”of the Ministry of Health of Russia, Moscow
² GBUZ“ Center for Pathology of Speech and Neurorebition of the Department of Health of the city of Moscow ”

Information is intended for medical and pharmaceutical workers. This information cannot serve as a replacement for a doctor’s consultation.

Source of photos and images Shutterstock.com